The purpose of the Text-to-SQL task is to bridge the gap between natural language and SQL queries. Current approaches mainly rely on large language models (LLMs), but employing them for Text-to-SQL ha ...

So many cool Fabric features get announced at Fabcon that it’s easy to miss some of them. The fact that you can now not only generate Excel files from Fabric Dataflows Gen2, but that you have so much ...

We'll be celebrating the gigs at this year's 6 Music Festival and beyond, and he'll be going record shopping with Luke Una.

Data work in 2026 asks for more than chart building. Professionals are expected to clean data, query databases, explain ...

New AI capabilities help DBAs move from performance visibility to performance resolution--turning slow queries into actionable index recommendations in minutes HOUSTON, March 19, 2026 /PRNewswire/ -- ...

Generate Biomedicines shares dropped nearly 21% Friday after the company’s $400 million initial public offering, continuing an uneven recovery for biotech stock-market debuts. After a biotech IPO ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate Biomedicines Inc. shares slumped 21% in the company’s trading debut after it raised $400 million in an initial public offering. Shares of the Somerville, Massachusetts-based drug developer ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...